PRECLINICAL ASSESSMENT OF TOPICAL TREATMENTS OF HERPES-SIMPLEX VIRUS-INFECTION - 5-PERCENT (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE CREAM

被引：13
|
作者：
FREEMAN, DJ
SACKS, SL
DECLERCQ, E
SPRUANCE, SL
机构：
[1] UNIV BRITISH COLUMBIA,DEPT MED,DIV INFECT DIS,VANCOUVER V6T 1W5,BC,CANADA
[2] UNIV UTAH,SCH MED,CTR INFECT DIS DIAGNOST MICROBIOL & IMMUNOL,SALT LAKE CITY,UT 84132
[3] CATHOLIC UNIV LEUVEN,REGA INST MED RES,B-3000 LOUVAIN,BELGIUM
来源：
ANTIVIRAL RESEARCH | 1985年 / 5卷 / 03期
关键词：
D O I：
10.1016/0166-3542(85)90049-X
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：169 / 177
页数：9
相关论文
共 50 条
  • [41] INFLUENCE OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE ON CORNEAL EPITHELIUM HEALING
    MAUDGAL, PC
    DEKIMPE, N
    DECLERCQ, E
    DESCAMPS, J
    MISSOTTEN, L
    GEYSEN, A
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1982, 218 (05) : 275 - 281
  • [42] (+/-)-CARBOCYCLIC (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE - A POTENT ANTIHERPES AGENT
    COOKSON, RC
    DUDFIELD, PJ
    NEWTON, RF
    RAVENSCROFT, P
    SCOPES, DIC
    CAMERON, JM
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1985, 20 (04) : 375 - 377
  • [43] SYNTHESIS OF 3'-MODIFIED ANALOGS OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE
    DYATKINA, NB
    KRAYEVSKY, AA
    GERMAN, G
    JANTALIPINSKI, M
    LANGEN, P
    YARTSEVA, IV
    BIOORGANICHESKAYA KHIMIYA, 1986, 12 (03): : 408 - 415
  • [44] SYNTHESIS AND ANTIVIRAL ACTIVITY OF (E)-5-(2-BROMOVINYL)URACIL AND (E)-5-(2-BROMOVINYL)URIDINE
    DECLERCQ, E
    DESGRANGES, C
    HERDEWIJN, P
    SIM, IS
    JONES, AS
    MCLEAN, MJ
    WALKER, RT
    JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (02) : 213 - 217
  • [45] DIFFERENTIAL BINDING AFFINITIES OF SUGAR-MODIFIED DERIVATIVES OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE FOR HERPES-SIMPLEX VIRUS-INDUCED AND HUMAN CELLULAR DEOXYTHYMIDINE KINASES
    ZOU, FC
    DUTSCHMAN, GE
    DECLERCQ, E
    CHENG, YC
    BIOCHEMICAL PHARMACOLOGY, 1984, 33 (11) : 1797 - 1800
  • [46] THE RELATIONSHIP BETWEEN INCORPORATION OF E-5-(2-BROMOVINYL)-2'-DEOXYURIDINE INTO HERPES-SIMPLEX VIRUS TYPE-1 DNA WITH VIRUS INFECTIVITY AND DNA INTEGRITY
    MANCINI, WR
    DECLERCQ, E
    PRUSOFF, WH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (02) : 792 - 795
  • [47] THERAPEUTIC EFFECT OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE, CAFFEIC ACID OXIDATION-PRODUCT, AND TRISODIUMPHOSPHONOFORMATE ON CUTANEOUS HERPES-SIMPLEX VIRUS TYPE-1 INFECTION IN GUINEA-PIGS
    HELBIG, B
    SAUERBREI, A
    KLOCKING, R
    WUTZLER, P
    WICHT, N
    WIEDEMANN, U
    HERRMANN, G
    JOURNAL OF MEDICAL VIROLOGY, 1987, 23 (03) : 303 - 309
  • [48] SYNTHESIS, MOLECULAR CONFORMATION AND ACTIVITY AGAINST HERPES SIMPLEX VIRUS OF (E)-5-(2-BROMOVINYL)-2′-DEOXYCYTIDINE ANALOGS
    Zoghaib, Wajdi Michel
    Mannala, Shajan
    Gupta, V. Sagar
    Tourigny, Guy
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2012, 31 (04): : 364 - 376
  • [49] TREATMENT OF EXPERIMENTAL HERPES-SIMPLEX VIRUS TYPE-1 ENCEPHALITIS IN MICE WITH (E)-5-(2-BROMOVINYL)- AND 5-VINYL-1-BETA-D-ARABINO-FURANOSYLURACIL - COMPARISON WITH BROMOVINYL-DEOXYURIDINE AND ACYCLOVIR
    REEFSCHLAGER, J
    WUTZLER, P
    THIEL, KD
    HERRMANN, G
    ANTIVIRAL RESEARCH, 1986, 6 (02) : 83 - 93
  • [50] DIFFERENTIAL PHOSPHORYLATION OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE MONOPHOSPHATE BY THYMIDYLATE KINASES FROM HERPES-SIMPLEX VIRUSES TYPE-1 AND TYPE-2 AND VARICELLA ZOSTER VIRUS
    FYFE, JA
    MOLECULAR PHARMACOLOGY, 1982, 21 (02) : 432 - 437
12345